@article{ShityakovSalvadorPastorinetal.2015,
  author    = {Shityakov, Sergey and Salvador, Ellaine and Pastorin, Giorgia and F{\"o}rster, Carola},
  title     = {Blood-brain barrier transport studies, aggregation, and molecular dynamics simulation of multiwalled carbon nanotube functionalized with fluorescein isothiocyanate},
  series = {International Journal of Nanomedicine},
  volume    = {10},
  journal   = {International Journal of Nanomedicine},
  doi       = {10.2147/IJN.S68429},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-149233},
  pages     = {1703-1713},
  year      = {2015},
  abstract  = {In this study, the ability of a multiwalled carbon nanotube functionalized with fluorescein isothiocyanate (MWCNT-FITC) was assessed as a prospective central nervous system-targeting drug delivery system to permeate the blood-brain barrier. The results indicated that the MWCNT-FITC conjugate is able to penetrate microvascular cerebral endothelial monolayers; its concentrations in the Transwell® system were fully equilibrated after 48 hours. Cell viability test, together with phase-contrast and fluorescence microscopies, did not detect any signs of MWCNT-FITC toxicity on the cerebral endothelial cells. These microscopic techniques also revealed presumably the intracellular localization of fluorescent MWCNT-FITCs apart from their massive nonfluorescent accumulation on the cellular surface due to nanotube lipophilic properties. In addition, the 1,000 ps molecular dynamics simulation in vacuo discovered the phenomenon of carbon nanotube aggregation driven by van der Waals forces via MWCN-TFITC rapid dissociation as an intermediate phase.},
  language  = {en}
}
@article{SalvadorShityakovFoerster2013,
  author    = {Salvador, Ellaine and Shityakov, Sergey and F{\"o}rster, Carola},
  title     = {Glucocorticoids and endothelial cell barrier function},
  series = {Cell and Tissue Research},
  volume    = {355},
  journal   = {Cell and Tissue Research},
  number    = {3},
  doi       = {10.1007/s00441-013-1762-z},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-132091},
  pages     = {597-605},
  year      = {2013},
  abstract  = {Glucocorticoids (GCs) are steroid hormones that have inflammatory and immunosuppressive effects on a wide variety of cells. They are used as therapy for inflammatory disease and as a common agent against edema. The blood brain barrier (BBB), comprising microvascular endothelial cells, serves as a permeability screen between the blood and the brain. As such, it maintains homeostasis of the central nervous system (CNS). In many CNS disorders, BBB integrity is compromised. GC treatment has been demonstrated to improve the tightness of the BBB. The responses and effects of GCs are mediated by the ubiquitous GC receptor (GR). Ligand-bound GR recognizes and binds to the GC response element located within the promoter region of target genes. Transactivation of certain target genes leads to improved barrier properties of endothelial cells. In this review, we deal with the role of GCs in endothelial cell barrier function. First, we describe the mechanisms of GC action at the molecular level. Next, we discuss the regulation of the BBB by GCs, with emphasis on genes targeted by GCs such as occludin, claudins and VE-cadherin. Finally, we present currently available GC therapeutic strategies and their limitations.},
  language  = {en}
}